Triple
T5425241
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | relapsing-remitting multiple sclerosis |
E121346
|
entity |
| Predicate | treatedWith |
P2367
|
FINISHED |
| Object | natalizumab |
E24936
|
NE FINISHED |
Named-entity recognition
Before disambiguation, gpt-5-mini classified whether the object phrase is a named entity — the step behind the object's NE type shown above.
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: natalizumab | Statement: [relapsing-remitting multiple sclerosis, treatedWith, natalizumab]
Disambiguation candidates (1 decision)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: natalizumab Context triple: [relapsing-remitting multiple sclerosis, treatedWith, natalizumab]
-
A.
Tysabri
chosen
Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
-
B.
Tecfidera
Tecfidera is an oral disease-modifying medication used to treat relapsing forms of multiple sclerosis by reducing inflammation and relapse frequency.
-
C.
Remicade
Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
D.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
E.
Stelara
Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd463b58d88190b258261573de9e91 |
elicitation | completed |
| NER | batch_69bd881598448190a9bb456dee36004b |
ner | completed |
| NED1 | batch_69bf3abbd1e481909ffb443812a9485a |
ned_source_triple | completed |
Created at: March 20, 2026, 2:06 p.m.